No Data
US Stock MarketDetailed Quotes
BLPH Bellerophon Therapeutics
Watchlist
0.034
-0.002-6.80% Close 11/30 16:00 ET
0.037High0.033Low22.27KVolume
0.037Open0.036Pre Close778.65Turnover0.19%Turnover RatioLossP/E (TTM)414.69KMarket Cap12.58052wk HighLossP/E (Static)12.23MShares0.02952wk Low0.11P/B403.64KFloat Cap193.800Historical High--Dividend TTM11.91MShs Float0.029Historical Low--Div YieldTTM11.00%Amplitude0.034Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Bellerophon Therapeutics Company
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
News
Bellerophon Therapeutics Insider Sold Shares Worth $111,776, According to a Recent SEC Filing
Puissance Capital Management Lp, 10% Owner, on October 13, 2023, sold 1,076,841 shares in Bellerophon Therapeutics (BLPH) for $111,776. SEC Filing: https://www.sec.gov/Archives/edgar/data/1600132/0001
Bellerophon Therapeutics(BLPH.US) 10% Shareholder Sells US$111.78K in Common Stocks
$Bellerophon Therapeutics(BLPH.US)$ 10% Shareholder Puissance Capital Management LP sold 1.08 million shares of Common Stocks on Oct 13, 2023 at an average price of $0.1038 for a total value of $111.7
12 Health Care Stocks Moving In Friday's After-Market Session
GainersBellerophon Therapeutics (NASDAQ:BLPH) stock moved upwards by 17.1% to $0.12 during Friday's after-market session. Trading volume for this security closed at 2.1 million, accounting for 1394.7%
Comments
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--